Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Organon & Co. < Previous 1 2 Next > European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 May 24, 2024 From Organon & Co. Via Business Wire Tickers OGN Organon Announces Pricing of $1.0 Billion Senior Notes Offering May 07, 2024 From Organon & Co. Via Business Wire Tickers OGN Organon Announces Proposed $1.0 Billion Senior Notes Offering May 07, 2024 From Organon & Co. Via Business Wire Tickers OGN Organon Reports Results for the First Quarter Ended March 31, 2024 May 02, 2024 From Organon & Co. Via Business Wire Tickers OGN Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024 April 08, 2024 From Organon & Co. Via Business Wire Tickers OGN Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoints April 08, 2024 From Organon & Co. Via Business Wire Tickers OGN Organon Announces HADLIMA™ (adalimumab-bwwd) Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary February 20, 2024 From Organon & Co. Via Business Wire Tickers OGN Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2023 February 15, 2024 From Organon & Co. Via Business Wire Tickers OGN Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 15, 2024 February 01, 2024 From Organon & Co. Via Business Wire Tickers OGN Organon’s XACIATO™ (clindamycin phosphate) Vaginal Gel 2% Available Nationwide to Treat Bacterial Vaginosis (BV) in Females Aged 12 and Older January 10, 2024 From Organon & Co. Via Business Wire Tickers OGN Organon affirms 2023 revenue and Adjusted EBITDA guidance and provides 2024 outlook January 08, 2024 From Organon & Co. Via Business Wire Tickers OGN Organon To Present at the 42nd Annual J.P. Morgan Healthcare Conference December 21, 2023 From Organon & Co. Via Business Wire Tickers OGN Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines December 18, 2023 From Organon & Co. Via Business Wire Tickers OGN Organon To Present at the Piper Sandler 35th Annual Healthcare Conference November 21, 2023 From Organon & Co. Via Business Wire Tickers OGN Organon Reports Results for the Third Quarter Ended September 30, 2023 November 02, 2023 From Organon & Co. Via Business Wire Tickers OGN Organon and Sempre Health Announce Collaboration on New Service to Help Eligible Patients Save Money and Stay on Their Medication as Prescribed November 01, 2023 From Organon & Co. Via Business Wire Tickers OGN Organon To Report Third Quarter Results and Host Conference Call on November 2, 2023 October 19, 2023 From Organon & Co. Via Business Wire Tickers OGN Organon Recognized on Fortune’s 2023 Change the World List for Leadership in Expanding Access to Contraceptive Choice September 27, 2023 From Organon & Co. Via Business Wire Tickers OGN First Real-World Observational Study of the JADA® System, a Medical Device to Control Postpartum Hemorrhage (PPH), Published in ACOG’s Obstetrics & Gynecology September 14, 2023 From Organon & Co. Via Business Wire Tickers OGN Organon Bolsters Research & Development Expertise with Two Leadership Appointments September 05, 2023 From Organon & Co. Via Business Wire Tickers OGN Organon Reports Results for the Second Quarter Ended June 30, 2023 August 08, 2023 From Organon & Co. Via Business Wire Tickers OGN Organon To Report Second Quarter Results and Host Conference Call on August 8, 2023 July 17, 2023 From Organon & Co. Via Business Wire Tickers OGN Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator July 01, 2023 From Organon & Co. Via Business Wire Tickers OGN Organon Publishes FY2022 ESG Report Showcasing Progress Toward Global Sustainability Goals June 27, 2023 From Organon & Co. Via Business Wire Tickers OGN Organon and CAF, Development Bank of Latin America, Launch First-of-Its-Kind Collaboration to Increase Sustainable Financing in Women’s Health June 07, 2023 From Organon & Co. Via Business Wire Tickers OGN Organon Reports Results for the First Quarter Ended March 31, 2023 May 04, 2023 From Organon & Co. Via Business Wire Tickers OGN Organon To Report First Quarter and Host Conference Call on May 4, 2023 April 20, 2023 From Organon & Co. Via Business Wire Tickers OGN Organon Launches “Her Plan is Her Power,” a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities Exist March 07, 2023 From Organon & Co. Via Business Wire Tickers OGN Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 16, 2023 February 06, 2023 From Organon & Co. Via Business Wire Tickers OGN Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy January 05, 2023 From Organon & Co. Via Business Wire Tickers OGN < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.